SRRM4 is a known regulator of alternative splicing, while NAV3 is reported to be involved in multiple immune and infection-associated pathways such as FoxO signaling, T cell activation, and Human papillomavirus infection pathways (24, 25). This evidence concerns the gene NAV3 and human papilloma virus infection.